{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:23:23Z","timestamp":1794936203666,"version":"4.9.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.reumae.2021.01.001","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T01:13:12Z","timestamp":1622682792000},"page":"91-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Relationship of IP-10 gene expression to systemic lupus erythematosus activity"],"prefix":"10.1016","volume":"18","author":[{"given":"Juli\u00e1n","family":"Torres-V\u00e1zquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn","family":"Uriel V\u00e1zquez-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Alberto","family":"Comoto-Santacruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano Emilio","family":"Pradillo-Macias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Eloy","family":"Mu\u00f1oz-Monroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Mart\u00ednez-Cuazitl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2021.01.001_bib0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/11310780-000000000-00000","article-title":"Cutaneous lupus erythematosus: issues in diagnosis and treatment","volume":"10","author":"Walling","year":"2009","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.reumae.2021.01.001_bib0010","first-page":"259","article-title":"Dickkopf-1 protein and systemic lupus erythematosus: new fields in research","volume":"23","author":"Caicedo","year":"2016","journal-title":"Rev Colomb Reumatol."},{"key":"10.1016\/j.reumae.2021.01.001_bib0015","first-page":"20","article-title":"\u00cdndice de actividad l\u00fapica y tratamiento del lupus eritematoso en dermatolog\u00eda","volume":"52","author":"Mini\u00f1o","year":"2008","journal-title":"Dermatolog\u00eda Rev Mex."},{"key":"10.1016\/j.reumae.2021.01.001_bib0020","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s00296-011-1962-3","article-title":"Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4","volume":"32","author":"Julkunen","year":"2012","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.reumae.2021.01.001_bib0025","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.3390\/ijms20194954","article-title":"Interferon-inducible protein 10 and disease activity in systemic lupus erythematosus and lupus nephritis: a systematic review and meta-analysis","volume":"20","author":"Puapatanakul","year":"2019","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.reumae.2021.01.001_bib0030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/08916930310001605873","article-title":"Induction of clinical autoimmune disease by therapeutic interferon-\u03b1","volume":"36","author":"Gota","year":"2003","journal-title":"Autoimmunity."},{"key":"10.1016\/j.reumae.2021.01.001_bib0035","first-page":"121","article-title":"CXCL10\/IP-10 in infectious diseases pathogenesis and potential therapeutic implications","volume":"22","author":"Liu","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.reumae.2021.01.001_bib0040","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1002\/art.24803","article-title":"Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study","volume":"60","author":"Bauer","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.reumae.2021.01.001_bib0045","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reumae.2021.01.001_bib0050","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/ar4451","article-title":"Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset","volume":"16","author":"Dominguez-Gutierrez","year":"2014","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.reumae.2021.01.001_bib0055","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/1529-0131(199908)42:8<1644::AID-ANR12>3.0.CO;2-L","article-title":"Th1\/Th2 balance of peripheral T helper cells in systemic lupus erythematosus","volume":"42","author":"Akahoshi","year":"1999","journal-title":"Arthritis Rheum."}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574321001209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574321001209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:01:07Z","timestamp":1761879667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574321001209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2173574321001209"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2021.01.001","relation":{},"ISSN":["2173-5743"],"issn-type":[{"value":"2173-5743","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship of IP-10 gene expression to systemic lupus erythematosus activity","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2021.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2021.01.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}